Synopsis
Synopsis
0
USDMF
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Altodor
2. Cyclonamine
3. Dicinone
4. Dicynene
5. Dicynone
6. Ethamsylate
7. Hemo 141
1. Ethamsylate
2. 2624-44-4
3. Cyclonamine
4. Aglumin
5. Dicynene
6. Ethamsylate [usan]
7. Md 141
8. Etamsilate
9. E 141
10. Etamsylate [inn]
11. Diethylamine 2,5-dihydroxybenzenesulfonate
12. Diethylamine Dobesilate
13. Benzenesulfonic Acid, 2,5-dihydroxy-, Compd. With N-ethylethanamine (1:1)
14. 24yl531voh
15. 2,5-dihydroxybenzenesulfonic Acid N-ethylethanamine (1:1)
16. Altodor
17. Benzenesulfonic Acid, 2,5-dihydroxy-, Compd. With Diethylamine
18. 2,5-dihydroxybenzenesulfonic Acid Compound With Diethylamine (1:1)
19. Md-141
20. Ethamsylate (usan)
21. Diethylammonium 2,5-dihydroxybenzenesulfonate
22. Ncgc00017041-01
23. Ciclonamina
24. Dicynone
25. Eselin
26. Cas-2624-44-4
27. E-141
28. 2,5-dihydroxybenzenesulfonic Acid N-ethylethanamine
29. 2,5-dihydroxybenzenesulfonic Acid;n-ethylethanamine
30. Ciclonamina [italian]
31. Etamsilato
32. Etamsylatum
33. Etamsylatum [inn-latin]
34. Etamsilato [inn-spanish]
35. Einecs 220-090-7
36. Unii-24yl531voh
37. Etamsylate,(s)
38. Diethylammonium Cyclohexadien-4-ol-1-one-4-sulfonate
39. Diidroxi-1,4-benzenesulfonato-3-di-etilammonium [italian]
40. 2,5-dihydroxybenzenesulfonic Acid Compd. With N-ethylethanamine
41. Etamsylate (jan/inn)
42. Etamsylate [jan]
43. Ethamsylate [mi]
44. 1-hydroxy-4-oxo-2,5-cyclohexadiene-1-sulfonic Acid Compd. With Diethylamine
45. Etamsylate [mart.]
46. Diidroxi-1,4-benzenesulfonato-3-di-etilammonium
47. Dsstox_cid_25559
48. Dsstox_rid_80956
49. Etamsilate [who-dd]
50. Dsstox_gsid_45559
51. Schembl34303
52. Chembl1514715
53. Dtxsid4045559
54. Chebi:31563
55. Amy8982
56. Etamsylate [ep Monograph]
57. C18e8
58. Hms1571k11
59. Hms2098k11
60. Hms3652i22
61. Hms3715k11
62. Bcp12254
63. Hy-b1074
64. Tox21_110752
65. Mfcd00867499
66. S4152
67. Akos005267176
68. Benzenesulfonic Acid, 2,5-dihydroxy-, Compd. With N-ethylethanamine(1:1)
69. Ccg-221015
70. Cs-4630
71. Db13483
72. Ks-1169
73. Ncgc00017041-02
74. Ncgc00017041-04
75. Ac-32031
76. Etamsylate 100 Microg/ml In Acetonitrile
77. Diethylamine 2,5-dihydroxy Benzene Sulfonate
78. E1145
79. Ft-0668047
80. Sw197271-3
81. D01282
82. F20533
83. 624e444
84. A847477
85. Sr-01000838306
86. Q2000876
87. Sr-01000838306-2
88. W-107184
89. 2,5-dihydroxybenzene- Sulfonic Acid Diethylamine Salt
90. 2,5-dihydroxybenzenesulfonic Acid N-ethylethanamine Salt
91. 2,5-dihydroxybenzenesulfonic Acidn-ethylethanamine (1:1)
Molecular Weight | 263.31 g/mol |
---|---|
Molecular Formula | C10H17NO5S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 3 |
Exact Mass | 263.08274382 g/mol |
Monoisotopic Mass | 263.08274382 g/mol |
Topological Polar Surface Area | 115 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 252 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Hemostatics
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)
B02BX01
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
B - Blood and blood forming organs
B02 - Antihemorrhagics
B02B - Vitamin k and other hemostatics
B02BX - Other systemic hemostatics
B02BX01 - Etamsylate
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Ethamsylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ethamsylate, including repackagers and relabelers. The FDA regulates Ethamsylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ethamsylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ethamsylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ethamsylate supplier is an individual or a company that provides Ethamsylate active pharmaceutical ingredient (API) or Ethamsylate finished formulations upon request. The Ethamsylate suppliers may include Ethamsylate API manufacturers, exporters, distributors and traders.
click here to find a list of Ethamsylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ethamsylate CEP of the European Pharmacopoeia monograph is often referred to as a Ethamsylate Certificate of Suitability (COS). The purpose of a Ethamsylate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ethamsylate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ethamsylate to their clients by showing that a Ethamsylate CEP has been issued for it. The manufacturer submits a Ethamsylate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ethamsylate CEP holder for the record. Additionally, the data presented in the Ethamsylate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ethamsylate DMF.
A Ethamsylate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ethamsylate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ethamsylate suppliers with CEP (COS) on PharmaCompass.
A Ethamsylate written confirmation (Ethamsylate WC) is an official document issued by a regulatory agency to a Ethamsylate manufacturer, verifying that the manufacturing facility of a Ethamsylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ethamsylate APIs or Ethamsylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Ethamsylate WC (written confirmation) as part of the regulatory process.
click here to find a list of Ethamsylate suppliers with Written Confirmation (WC) on PharmaCompass.
Ethamsylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ethamsylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ethamsylate GMP manufacturer or Ethamsylate GMP API supplier for your needs.
A Ethamsylate CoA (Certificate of Analysis) is a formal document that attests to Ethamsylate's compliance with Ethamsylate specifications and serves as a tool for batch-level quality control.
Ethamsylate CoA mostly includes findings from lab analyses of a specific batch. For each Ethamsylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ethamsylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ethamsylate EP), Ethamsylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ethamsylate USP).
LOOKING FOR A SUPPLIER?